| Brain iron deposition is linked with cognitive severity in Parkinson’s disease GEC Thomas, LA Leyland, AE Schrag, AJ Lees, J Acosta-Cabronero, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (4), 418-425, 2020 | 199 | 2020 |
| Sequence of clinical and neurodegeneration events in Parkinson’s disease progression NP Oxtoby, LA Leyland, LM Aksman, GEC Thomas, EL Bunting, ... Brain 144 (3), 975-988, 2021 | 88 | 2021 |
| Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease GEC Thomas, A Zarkali, M Ryten, K Shmueli, AL Gil-Martinez, LA Leyland, ... Brain 144 (6), 1787-1798, 2021 | 81 | 2021 |
| Measuring physiological responses to the arts in people with a dementia GEC Thomas, SJ Crutch, PM Camic, S on behalf of the Created International Journal of Psychophysiology 123, 64-73, 2018 | 38 | 2018 |
| Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson’s disease GEC Thomas, P Zeidman, T Sultana, A Zarkali, A Razi, RS Weil Brain Communications 5 (1), fcac329, 2023 | 28 | 2023 |
| Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression R Bhome, A Zarkali, GEC Thomas, JE Iglesias, JH Cole, RS Weil npj Parkinson's Disease 8 (1), 2, 2022 | 14 | 2022 |
| Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions A Zarkali, GEC Thomas, H Zetterberg, RS Weil Nature Communications 15 (1), 5661, 2024 | 12 | 2024 |
| Longitudinal associations of magnetic susceptibility with clinical severity in Parkinson's disease GEC Thomas, N Hannaway, A Zarkali, K Shmueli, RS Weil Movement Disorders 39 (3), 546-559, 2024 | 8 | 2024 |
| Structural and functional imaging correlates of visual hallucinations in Parkinson’s disease R Bhome, GEC Thomas, A Zarkali, RS Weil Current Neurology and Neuroscience Reports 23 (6), 287-299, 2023 | 7 | 2023 |
| Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes N Hannaway, A Zarkali, R Bhome, I Dobreva, GEC Thomas, E Veleva, ... bioRxiv, 2025.01. 24.634687, 2025 | | 2025 |
| Impaired glymphatic clearance independently contributes to poor outcomes in Parkinsons disease A Zarkali, GEC Thomas, R Patterson, N Hannaway, I Dobreva, ... bioRxiv, 2025.01. 15.633106, 2025 | | 2025 |
| Magnetic susceptibility is predictive of future clinical severity in Parkinson’s disease GEC Thomas, N Hannaway, A Zarkali, K Shmueli, RS Weil medRxiv, 2023.07. 12.23292555, 2023 | | 2023 |
| Using neuroimaging to track symptom severity and dysfunctional brain networks in Parkinson’s disease progression G Thomas UCL (University College London), 2023 | | 2023 |
| Regional brain iron and gene expression variation in Parkinson's disease G Thomas, A Zarkali, M Ryten, K Shmueli, AL Martinez, LA Leyland, ... MOVEMENT DISORDERS 36, S379-S380, 2021 | | 2021 |
| Brain iron deposition is linked with cognitive severity in Parkinson's disease (vol 91, pg 418, 2020) GEC Thomas, LA Leyland, A Schrag JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 92 (5), E2-E2, 2021 | | 2021 |
| Using Quantitative Susceptibility Mapping to Predict Dementia in Parkinson's Disease G Thomas, L Leyland, J Acosta-Cabronero, R Weil MOVEMENT DISORDERS 34, 2019 | | 2019 |
| Supplementary methods Supplementary tables 1-3 Supplementary figures 1-11 GEC Thomas, N Hannaway, A Zarkali, K Shmueli, RS Weil | | |